A study finds that a targeted therapy approved to treat advanced breast cancer lengthens survival, and data indicate that Medicaid expansion has helped ease racial disparities in access to cancer care.

by Kate Yandell

A study finds that oral cancer medication costs for patients covered by Medicare Part D have increased, and the U.S. Food and Drug Administration approves a new targeted therapy for advanced breast cancer.

by Kate Yandell

Unequal access to care appears to be responsible for the elevated mortality rate from prostate cancer in black men, and women with a history of cancer who identify as lesbian or bisexual have reduced access to care.

by Kate Yandell

A study indicates that the Affordable Care Act decreased the proportion of people with a history of cancer who are uninsured, and access to appropriate targeted therapies may be lacking for some patients.

by Kate Yandell

The spread of measles raises concerns among some cancer patients, and a treatment for early-stage HER2-positive breast cancer is approved by the U.S. Food and Drug Administration.

by Kate Yandell and Bradley Jones

Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.

by Bradley Jones

A study indicates that the majority of patients using immune checkpoint inhibitors experience side effects, and radiation oncologists say that requirements for prior authorization are impeding care.

by Kate Yandell

The CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.

by Kate Yandell

Cancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.

by Kate Yandell

People with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.

by Marci A. Landsmann and Kate Yandell